StockData
Akari Therapeutics Plc logo

Akari Therapeutics Plc (AKTX) stock

AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 0/30
$6.65+0.95 (+16.67%)

Close on Nov 18, 2026Market cap $12.95MP/E –Yield –

Akari Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Akari Therapeutics's market cap was $13.04M on Nov 11, 2026, against $15.86M a year earlier. Over the last 5 years it ranged from $5.83M to $70.63M, with a median of $19.99M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$13.04M+38.4%
2025Dec 31, 2025$9.43M-36.4%
2024Dec 31, 2024$14.82M-6.2%
2023Dec 29, 2023$15.79M-43.4%
2022Dec 30, 2022$27.89M-51.7%
2021Dec 31, 2021$57.71M+12.8%
2020Dec 31, 2020$51.18M+89.9%
2019Dec 31, 2019$26.96M+12.5%
2018Dec 31, 2018$23.95M-53.0%
2017Dec 29, 2017$50.99M-38.5%
2016Dec 30, 2016$82.91M-51.4%
2015Dec 31, 2015$170.77M-32.0%
2014Dec 31, 2014$251.02M–

More Akari Therapeutics figures

See a number that looks wrong?